Bo Hjorth Bentzen

Bo Hjorth Bentzen

Associate Professor

ORCID: 0000-0002-0253-4992

Publication year:
All
1 - 1 out of 1Page size: 10
  1. 2024
  2. E-pub ahead of print

    A phase 1 trial of AP30663, a KCa2 channel inhibitor in development for conversion of atrial fibrillation

    Yfanti, C., Vestbjerg, B., van't Westende, J., Edvardsson, N., Monfort, L. M., Olesen, Morten Steen Salling, Bentzen, Bo Hjorth, Grunnet, Morten, Eveleens Maarse, B. C., Diness, Jonas Goldin, Kemme, M. J. B., Sørensen, U., Moerland, M., van Esdonk, M. J., Klaassen, E. S., Gal, P. & Holst, A. G., 2024, (E-pub ahead of print) In: British Journal of Clinical Pharmacology.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 13529